{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T04:17:38Z","timestamp":1778905058700,"version":"3.51.4"},"reference-count":50,"publisher":"The Japanese Society for Neuroendovascular Therapy","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["NOUSHINKEI KEKKANNAI TIRYOU","JNET"],"published-print":{"date-parts":[[2026]]},"DOI":"10.5797\/jnet.ra.2025-0153","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T22:09:37Z","timestamp":1778623777000},"page":"n\/a","source":"Crossref","is-referenced-by-count":0,"title":["Current Status of Middle Meningeal Artery Embolization for Chronic Subdural Hematoma: An International Perspective Including Japan"],"prefix":"10.5797","volume":"20","author":[{"given":"Masato","family":"Kawakami","sequence":"first","affiliation":[{"name":"Department of Neurological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Okayama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Sugiu","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Okayama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Hiramatsu","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Okayama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Haruma","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Okayama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryu","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Okayama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuta","family":"Soutome","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Okayama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juntaro","family":"Fujita","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Okayama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Hirata","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Okayama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fukiko","family":"Baba","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Okayama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shota","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Okayama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3804","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Balser D, Farooq S, Mehmood T, et al. Actual and projected incidence rates for chronic subdural hematomas in United States Veterans Administration and civilian populations. <i>J Neurosurg<\/i> 2015; 123: 1209\u20131215.","DOI":"10.3171\/2014.9.JNS141550"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Santarius T, Kirkpatrick PJ, Ganesan D, et al. Use of drains versus no drains after burr-hole evacuation of chronic subdural haematoma: a randomised controlled trial. <i>Lancet<\/i> 2009; 374: 1067\u20131073.","DOI":"10.1016\/S0140-6736(09)61115-6"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Ryu SM, Yeon JY, Kong DS, et al. Risk of recurrent chronic subdural hematoma associated with early warfarin resumption: a matched cohort study. <i>World Neurosurg<\/i> 2018; 120: e855\u2013e862.","DOI":"10.1016\/j.wneu.2018.08.177"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Lakhani DA, Balar AB, Boo S, et al. Middle meningeal artery embolization with surgical evacuation improves outcomes in chronic subdural hematoma: a multi-institutional and multinational database study. <i>J Neurointerv Surg<\/i> 2026; 18: 86\u201390.","DOI":"10.1136\/jnis-2024-022932"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Moshayedi P, Liebeskind DS. Middle meningeal artery embolization in chronic subdural hematoma: implications of pathophysiology in trial design. <i>Front Neurol<\/i> 2020; 11: 923.","DOI":"10.3389\/fneur.2020.00923"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Mandai S, Sakurai M, Matsumoto Y. Middle meningeal artery embolization for refractory chronic subdural hematoma. Case report. <i>J Neurosurg<\/i> 2000; 93: 686\u2013688.","DOI":"10.3171\/jns.2000.93.4.0686"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Davies JM, Knopman J, Mokin M, et al. Adjunctive middle meningeal artery embolization for subdural hematoma. <i>N Engl J Med<\/i> 2024; 391: 1890\u20131900.","DOI":"10.1056\/NEJMoa2313472"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Fiorella D, Monteith SJ, Hanel R, et al. Embolization of the middle meningeal artery for chronic subdural hematoma. <i>N Engl J Med<\/i> 2025; 392: 855\u2013864.","DOI":"10.1056\/NEJMoa2409845"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Liu J, Ni W, Zuo Q, et al. Middle meningeal artery embolization for nonacute subdural hematoma. <i>N Engl J Med<\/i> 2024; 391: 1901\u20131912.","DOI":"10.1056\/NEJMoa2401201"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Toi H, Kinoshita K, Hirai S, et al. Present epidemiology of chronic subdural hematoma in Japan: analysis of 63,358 cases recorded in a national administrative database. <i>J Neurosurg<\/i> 2018; 128: 222\u2013228.","DOI":"10.3171\/2016.9.JNS16623"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Uno M, Toi H, Hirai S. Chronic subdural hematoma in elderly patients: is this disease benign? <i>Neurol Med Chir (Tokyo)<\/i> 2017; 57: 402\u2013409.","DOI":"10.2176\/nmc.ra.2016-0337"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Murai S, Ebisudani Y, Haruma J, et al. Nationwide survey of middle meningeal artery embolization for chronic subdural hematoma in Japan. <i>Neurol Med Chir (Tokyo)<\/i> 2025; 65: 319\u2013325.","DOI":"10.2176\/jns-nmc.2025-0003"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Nakagawa I, Kotsugi M, Yokoyama S, et al. Extensive roles and technical advances of middle meningeal artery embolization for chronic subdural hematoma. <i>Neurol Med Chir (Tokyo)<\/i> 2023; 63: 327\u2013333.","DOI":"10.2176\/jns-nmc.2023-0017"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Vollherbst DF, Berlis A, Zaki M, et al. Middle meningeal artery embolization for the treatment of chronic subdural hematomas\u2014a German nationwide multi-center study on 718 embolizations. <i>Clin Neuroradiol<\/i> 2026; 36: 49\u201358.","DOI":"10.1007\/s00062-025-01549-w"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Dicpinigaitis AJ, Al-Mufti F, Cooper JB, et al. Nationwide trends in middle meningeal artery embolization for treatment of chronic subdural hematoma: a population-based analysis of utilization and short-term outcomes. <i>J Clin Neurosci<\/i> 2021; 94: 70\u201375.","DOI":"10.1016\/j.jocn.2021.10.001"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) McCann CP, Brandel MG, Wali AR, et al. Safety of middle meningeal artery embolization for treatment of subdural hematoma: a nationwide propensity score matched analysis. <i>J Cerebrovasc Endovasc Neurosurg<\/i> 2023; 25: 380\u2013389.","DOI":"10.7461\/jcen.2023.E2023.05.003"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Khorasanizadeh M, Maroufi SF, Mukherjee R, et al. Middle meningeal artery embolization in adjunction to surgical evacuation for treatment of subdural hematomas: a nationwide comparison of outcomes with isolated surgical evacuation. <i>Neurosurgery<\/i> 2023; 93: 1082\u20131089.","DOI":"10.1227\/neu.0000000000002554"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Tong X, Xue X, Liu A, et al. Comparative study on clinical outcomes and cost-effectiveness of chronic subdural hematomas treated by middle meningeal artery embolization and conventional treatment: a national cross-sectional study. <i>Int J Surg<\/i> 2023; 109: 3836\u20133847.","DOI":"10.1097\/JS9.0000000000000699"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) De Maria L, Chaurasia B, Agosti E, et al. Non-surgical management of chronic subdural hematoma: insights and future perspectives from an international survey including neurosurgeons from 90 countries worldwide. <i>Int J Neurosci<\/i> 2025; 135: 70\u201379.","DOI":"10.1080\/00207454.2023.2286202"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Bartek J, Biondi A, Bonhomme V, et al. Multidisciplinary consensus-based statement on the current role of middle meningeal artery embolization (MMAE) in chronic SubDural hematoma (cSDH). <i>Brain Spine<\/i> 2024; 4: 104143.","DOI":"10.1016\/j.bas.2024.104143"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Ironside N, Nguyen C, Do Q, et al. Middle meningeal artery embolization for chronic subdural hematoma: a systematic review and meta-analysis. <i>J Neurointerv Surg<\/i> 2021; 13: 951\u2013957.","DOI":"10.1136\/neurintsurg-2021-017352"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Kan P, Fiorella D, Dabus G, et al. ARISE I consensus statement on the management of chronic subdural hematoma. <i>Stroke<\/i> 2024; 55: 1438\u20131448.","DOI":"10.1161\/STROKEAHA.123.044129"},{"key":"23","unstructured":"23) The National Institute for Health and Care Excellence (NICE). Middle Meningeal Artery Embolisation for Chronic Subdural Haematomas. 2023. https:\/\/www.nice.org.uk\/guidance\/ipg779 (Accessed: November 30, 2025)."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Siddiq F, Shakir M, Nguyen TN, et al. Consensus statement on middle meningeal artery embolization in chronic subdural hematoma treatment: a guideline from the Society of Vascular and Interventional Neurology Guidelines and Practice Standards Committee. <i>Stroke Vasc Interv Neurol<\/i> 2025; 5: e001814.","DOI":"10.1161\/SVIN.125.001814"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Fakhry R, Yesildal C, Bartek J, et al. Updated systematic review of current randomised controlled trials in chronic subdural haematoma. <i>Acta Neurochir (Wien)<\/i> 2025; 167: 288.","DOI":"10.1007\/s00701-025-06683-5"},{"key":"26","doi-asserted-by":"publisher","unstructured":"26) Gajjar AA, Naqvi A, Chen JY, et al. 2024 middle meningeal artery embolization trials: a comprehensive review of past, recent, and ongoing trials. <i>Interv Neuroradiol<\/i> 2025 Apr 4. 2025. doi.org\/10.1177\/15910199251329970. [Epub ahead of print]","DOI":"10.1177\/15910199251329970"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Jensen TSR, Duerinck J, Holl D, et al. Letter-to-the-editor to the study by Bartek J et al \u201cMultidisciplinary consensus-based statement on the current role of Middle Meningeal Artery embolization (MMAE) in chronic SubDural Hematoma (cSDH)\u201d \u2013 A letter from the international CSDH research group committee, iCORIC. <i>Brain Spine<\/i> 2025; 5: 104169.","DOI":"10.1016\/j.bas.2024.104169"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Papageorgiou NM, Palaiodimou L, Melanis K, et al. Embolization of middle meningeal artery in patients with chronic subdural hematoma: a systematic review and meta-analysis of randomized-controlled clinical trials. <i>J Clin Med<\/i> 2025; 14: 2862.","DOI":"10.3390\/jcm14092862"},{"key":"29","doi-asserted-by":"publisher","unstructured":"29) Mortezaei A, Al-Saidi N, Yahyaei K, et al. Middle meningeal artery embolization versus standard of care for chronic subdural hematoma: meta-analysis of randomized controlled trials. <i>Neuroradiol J<\/i> 2025 Oct 21. 2025. doi.org\/10.1177\/19714009251389579. [Epub ahead of print]","DOI":"10.1177\/19714009251389579"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Jayakumar N, Kennion O, Coulter I. Middle meningeal artery embolisation reduces chronic subdural haematoma recurrence: a meta-analysis of EMBOLISE, STEM, MAGIC-MT and EMPROTECT trials and cost analysis. <i>Clin Neurol Neurosurg<\/i> 2025; 258: 109128.","DOI":"10.1016\/j.clineuro.2025.109128"},{"key":"31","doi-asserted-by":"publisher","unstructured":"31) Shankar J. Embolization of middle meningeal artery (EMMA) for non-acute subdural hematoma: insight from recent randomized trials and meta-analysis. <i>Interv Neuroradiol<\/i> 2025 Feb 3. 2025. doi.org\/10.1177\/15910199251318408. [Epub ahead of print]","DOI":"10.1177\/15910199251318408"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Gillespie CS, Veremu M, Cook WH, et al. Middle meningeal artery embolization for chronic subdural hematoma: meta-analysis of three randomized controlled trials and review of ongoing trials. <i>Acta Neurochir (Wien)<\/i> 2025; 167: 166.","DOI":"10.1007\/s00701-025-06587-4"},{"key":"33","unstructured":"33) Spahn J. Chronic Subdural Hematoma Treatment With Embolization Versus Surgery Study (CHESS). https:\/\/clinicaltrials.gov\/study\/NCT06347796 (Accessed: November 30, 2025)."},{"key":"34","unstructured":"34) Holmberg \u00c5. Swedish Trial on Embolization of Middle Meningeal Artery Versus Surgical Evacuation in Chronic Subdural Hematoma (SWEMMA). https:\/\/clinicaltrials.gov\/study\/NCT05267184 (Accessed: November 30, 2025)."},{"key":"35","unstructured":"35) Perez MMG. Puerto Rico Embolization of the Middle Meningeal Artery for the Treatment of Chronic Subdural Hematoma Trial (PREMMA). https:\/\/clinicaltrials.gov\/study\/NCT06466733 (Accessed: November 30, 2025)."},{"key":"36","unstructured":"36) Castellan L. Endovascular vs Conservative Treatment in Patients With Chronic Subdural Hematomas and Mild Symptoms. https:\/\/clinicaltrials.gov\/study\/NCT06274580 (Accessed: November 30, 2025)."},{"key":"37","unstructured":"37) The Onyx\u2122 Trial For The Embolization Of The Middle Meningeal Artery For Chronic Subdural Hematoma (OTEMACS). https:\/\/clinicaltrials.gov\/study\/NCT04742920 (Accessed: November 30, 2025)."},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Shotar E, Mathon B, Salle H, et al. Meningeal Embolization for preventing chronic subdural hematoma recurrence after surgery: the EMPROTECT randomized clinical trial. <i>JAMA<\/i> 2025; 334: 127\u2013135.","DOI":"10.1001\/jama.2025.7583"},{"key":"39","unstructured":"39) Uchida K. Middle Meningeal Artery Embolization for Patients With Chronic Subdural Hematoma. https:\/\/clinicaltrials.gov\/study\/NCT06772740 (Accessed: November 30, 2025)."},{"key":"40","unstructured":"40) Jianwei P. Middle meningeal artery embolization versus traditional remedy for high-risk intractable chronic subdural hematomas. https:\/\/www.chictr.org.cn\/showprojEN.html?proj=52924 (Accessed: November 30, 2025)."},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Al Awadhi A, Mollica C, Da Broi M, et al. Middle meningeal artery (MMA) embolisation for chronic subdural haematomas: rationale and design for the STOp Recurrence of MMA Bleeding (STORMM) randomised control trial\u2014a study protocol. <i>BMJ Open<\/i> 2025; 15: e092014.","DOI":"10.1136\/bmjopen-2024-092014"},{"key":"42","unstructured":"42) Middle Meningeal Artery Embolization for the Treatment of Subdural Hematomas With TRUFILL\u00ae n-BCA (MEMBRANE). https:\/\/clinicaltrials.gov\/study\/NCT04816591 (Accessed: November 30, 2025)."},{"key":"43","unstructured":"43) GENTRIC j-C. Efficacy of a Minimally Invasive Therapy Adjuvant to the Standards of Care by Cyanoacrylate Embolization (LEADH). https:\/\/clinicaltrials.gov\/study\/NCT05374681 (Accessed: November 30, 2025)."},{"key":"44","unstructured":"44) Verbaan D. Embolization of Middle Meningeal Artery in Chronic Subdural Hematoma (ELIMINATE). https:\/\/clinicaltrials.gov\/study\/NCT04511572 (Accessed: November 30, 2025)."},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Han S, Feng Y, Xu C, et al. Brain re-expansion predict the recurrence of unilateral CSDH: a clinical grading system. <i>Front Neurol<\/i> 2022; 13: 908151.","DOI":"10.3389\/fneur.2022.908151"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Salem MM, Sioutas GS, Khalife J, et al. General versus nongeneral anesthesia for middle meningeal artery embolization for chronic subdural hematomas: multicenter propensity score matched study. <i>Neurosurgery<\/i> 2024; 95: 76\u201386.","DOI":"10.1227\/neu.0000000000002885"},{"key":"47","unstructured":"47) Hancheng Q. Endovascular therapy combined with operation and simple operation in the treatment of chronic subdural hematoma: a randomized controlled trial. https:\/\/www.chictr.org.cn\/showprojEN.html?proj=63263 (Accessed: November 30, 2025)."},{"key":"48","unstructured":"48) Tomasello A. Endovascular Embolization of Chronic Subdural Hematomas After Surgery (ENCLOSURE). https:\/\/clinicaltrials.gov\/study\/NCT05220826 (Accessed: November 30, 2025)."},{"key":"49","unstructured":"49) Lemcke J. Preventing Recurrences of Chronic Subdural Hematoma in Adult Patients by Middle Meningeal Artery Embolization (MEMBRANE). https:\/\/clinicaltrials.gov\/study\/NCT05327933 (Accessed: November 30, 2025)."},{"key":"50","unstructured":"50) Shankar J. Management of CSDH With or Without EMMA- a Randomized Control Trial (EMMA-Can). https:\/\/clinicaltrials.gov\/study\/NCT04750200 (Accessed: November 30, 2025)."}],"container-title":["Journal of Neuroendovascular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnet\/20\/1\/20_ra.2025-0153\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T04:05:03Z","timestamp":1778904303000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnet\/20\/1\/20_ra.2025-0153\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.5797\/jnet.ra.2025-0153","relation":{},"ISSN":["1882-4072","2186-2494"],"issn-type":[{"value":"1882-4072","type":"print"},{"value":"2186-2494","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"ra.2025-0153"}}